awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47582481-B14410B5-4145-4A0A-9815-84F48BEA0647
Q47582481-B14410B5-4145-4A0A-9815-84F48BEA0647
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47582481-B14410B5-4145-4A0A-9815-84F48BEA0647
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
P2860
Q47582481-B14410B5-4145-4A0A-9815-84F48BEA0647
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47582481-B14410B5-4145-4A0A-9815-84F48BEA0647
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f58aaededc7a960a664a994320b3405838173a4
P2860
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial.